Familial Hypercholesterolemia News and Research

RSS
GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Genzyme announces fourth-quarter and full-year 2009 financial results

Genzyme announces fourth-quarter and full-year 2009 financial results

Pediatric data for Pfizer's Lipitor submitted to the EMEA

Pediatric data for Pfizer's Lipitor submitted to the EMEA

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

FDA approves Daiichi Sankyo's sNDA for Welchol

FDA approves Daiichi Sankyo's sNDA for Welchol

Drug pactimibe does not appear to reduce progression of atherosclerosis

Drug pactimibe does not appear to reduce progression of atherosclerosis

Major discovery in the control of bad cholesterol

Major discovery in the control of bad cholesterol

Issues on cholesterol: diet, statins and genetics

Issues on cholesterol: diet, statins and genetics

Lipid Association responds to new cholesterol guidelines for kids

Lipid Association responds to new cholesterol guidelines for kids

Improving statins

Improving statins

Statin drugs may delay progressive artery damage in children

Statin drugs may delay progressive artery damage in children

One-third to nearly one-half of all children and adolescents should be tested for cholesterol levels

One-third to nearly one-half of all children and adolescents should be tested for cholesterol levels

Schering-Plough announces ZETIA spproved in Japan

Schering-Plough announces ZETIA spproved in Japan

Addition of torcetrapib to statin therapy has no benefit for atherosclerosis progression

Addition of torcetrapib to statin therapy has no benefit for atherosclerosis progression

Targeted Genetics announces new patent for Hyperlipidemia

Targeted Genetics announces new patent for Hyperlipidemia

Completion of the sequencing of human chromosome 19

Completion of the sequencing of human chromosome 19